134 related articles for article (PubMed ID: 38294744)
41. Long-term clinical effect of Tangyiping Granules () on patients with impaired glucose tolerance.
Huang YQ; Yang QF; Wang H; Xu YS; Peng W; Jiang YH
Chin J Integr Med; 2016 Sep; 22(9):653-9. PubMed ID: 27614450
[TBL] [Abstract][Full Text] [Related]
42. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Guo J; Chen H; Zhang X; Lou W; Zhang P; Qiu Y; Zhang C; Wang Y; Liu WJ
Oxid Med Cell Longev; 2021; 2021():2074610. PubMed ID: 34956436
[TBL] [Abstract][Full Text] [Related]
43. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus.
Keskin L; Yaprak B
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6813-6820. PubMed ID: 36196729
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i.
Blonde L; Fainberg U; Kaltoft MS; Mosenzon O; Ramesh C; Rea R
Diabetes Obes Metab; 2021 Oct; 23(10):2234-2241. PubMed ID: 34132018
[TBL] [Abstract][Full Text] [Related]
46. [Effects of rosiglitazone on endothelium-dependent vasodilation in patients with Type 2 diabetes].
Wu J; Lei MX; Liu L; Huang YJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):570-4. PubMed ID: 16951521
[TBL] [Abstract][Full Text] [Related]
47. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
[TBL] [Abstract][Full Text] [Related]
48. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
49. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
[TBL] [Abstract][Full Text] [Related]
50. Long-term effectiveness and safety of liraglutide in clinical practice.
Ponzani P
Minerva Endocrinol; 2013 Mar; 38(1):103-12. PubMed ID: 23435446
[TBL] [Abstract][Full Text] [Related]
51. Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention.
Zhou W; Ye SD; Chen C; Wang W
J Diabetes Res; 2018; 2018():7329861. PubMed ID: 30186876
[TBL] [Abstract][Full Text] [Related]
52. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio.
Yang M; Zhou X; Xu J; Yang B; Yu J; Gong Q; Zhang X; Sun X; Zhang Q; Xia J; Li J
Bosn J Basic Med Sci; 2019 Nov; 19(4):328-335. PubMed ID: 31078135
[TBL] [Abstract][Full Text] [Related]
53. [Effect of panax quinquefolius saponin on insulin sensitivity in patients of coronary heart disease with blood glucose abnormality].
Zhang Y; Lu S; Liu YY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1066-9. PubMed ID: 18198636
[TBL] [Abstract][Full Text] [Related]
54. [Acupuncture intervention induced improvement of oxidative stress by regulating PKCβ/P66shc signaling in obese diabetic rats].
Yin G; Shen GM; Jiang AJ; Li JY
Zhen Ci Yan Jiu; 2021 Aug; 46(8):642-8. PubMed ID: 34472748
[TBL] [Abstract][Full Text] [Related]
55. Predictive Value of Homeostasis Model Assessment of Insulin Resistance, Visceral Fat Index, and Prepregnancy Body Mass Index in Gestational Metabolic Syndrome.
Zhao L; Huang L
Evid Based Complement Alternat Med; 2021; 2021():6709725. PubMed ID: 34603475
[TBL] [Abstract][Full Text] [Related]
56. [Regulative effects of the acupuncture on glucose and lipid metabolism disorder in the patients of metabolic syndrome].
Chen J; Xing H; Li Q; Li M; Wang S
Zhongguo Zhen Jiu; 2017 Apr; 37(4):361-365. PubMed ID: 29231585
[TBL] [Abstract][Full Text] [Related]
57. Effect of Tang No.1 granule (1) in treating patients with impaired glucose tolerance.
WEI Y; HONG YZ; YE X
Chin J Integr Med; 2008 Dec; 14(4):298-302. PubMed ID: 19082803
[TBL] [Abstract][Full Text] [Related]
58. Clinical Efficacy of Polyethylene Glycol Loxenatide in the Treatment of Obese or Overweight Patients with Type 2 Diabetes Mellitus.
Song X; Yao M; Li Z; Guo S; Yin F; Li R
J Coll Physicians Surg Pak; 2023 Dec; 33(12):1390-1394. PubMed ID: 38062594
[TBL] [Abstract][Full Text] [Related]
59. [Regulatory effect of liraglutide on the expression of eNOS in the corpus cavernosum of diabetic rats].
Yue L; Xu JL; Dong J; Xjang GD; Xiang L; Zhao LS; Zhang JX; Zhai ZY; Zhu GP; Liu M; Ni J; Wang Y
Zhonghua Nan Ke Xue; 2016 Mar; 22(3):212-8. PubMed ID: 27172659
[TBL] [Abstract][Full Text] [Related]
60. Protective effects of modified linggui zhugan decoction combined with short-term very low calorie diets on cardiovascular risk factors in obese patients with impaired glucose tolerance.
Ke B; Shi L; Jun-jie Z; Chen DS; Meng J; Qin J
J Tradit Chin Med; 2012 Jun; 32(2):193-8. PubMed ID: 22876442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
